Podocyte specific assays and uses thereof
AssigneeUniversity of Miami
InventorJochen Reiser
Life of this patent
Estimating the term…
Abstract
Compositions are directed to the treatment of kidney diseases in a cell-specific manner. Methods of treating kidney diseases comprise the use of the compositions. Assays for identification of further compounds are provided.
Claims30
A method of measuring or quantifying calcineurin activity in vitro or in vivo comprising:
- transforming a cell with a reporter construct, wherein the reporter construct comprising a polynucleotide encoding a nuclear factor of activated T cells (NFAT);
- a selectable marker and a reporter gene;
- measuring NFAT activity in the sample;
- correlating NFAT activity to calcineurin activity;
- and;
- measuring or quantifying calcineurin activity.
A reporter construct comprising:
- polynucleotide encoding a nuclear factor of activated T cells (NFAT), fragments or mutants thereof;
- a selectable marker and a reporter gene.
A method of diagnosing an immune-related disease or condition in a patient comprising:
- obtaining a sample from a patient and measuring NFAT activity in the sample;
- correlating NFAT activity to calcineurin activity;
- and,
- diagnosing an immune-related disease or condition in a patient.
A method of diagnosing kidney disease or condition in a patient comprising:
- obtaining a sample from a patient and measuring NFAT activity in the sample;
- correlating NFAT activity to calcineurin activity;
- and,
- diagnosing kidney disease or condition in a patient.
A method of diagnosing cancer in a patient comprising:
- obtaining a sample from a patient and measuring NFAT activity in the sample;
- correlating NFAT activity to calcineurin activity;
- and,
- diagnosing cancer in a patient.
A method of screening and identifying novel therapeutic compounds comprising:
- contacting an NFAT molecule or a cell comprising a reporter construct, wherein the reporter construct comprising a polynucleotide encoding a nuclear factor of activated T cells (NFAT), a selectable marker and a reporter gene;
- measuring NFAT activity in the presence or absence of the compound;
- correlating NFAT activity to calcineurin activity;
- and;
- screening and identifying novel therapeutic compounds.
A composition comprising at least one agent wherein the agent modulates NFAT expression, function or activity in vivo.
A composition comprising a therapeutically effective amount of at least one agent which modulates expression, function or activity of transient receptor potential cation channels (TRPC) in vivo.
A method of treating kidney diseases or disorders in a patient, comprising administering to a patient in need thereof, a therapeutically effective amount of at least one agent which modulates expression, function or activity of at least one TRPC as compared to a normal control, and;
- treating a kidney disease or disorder.
Dependencies are inferred from the claim text.